Nulliparity was also associated with specific characteristics of breast cancer, including larger tumour size (> 20 mm), high levels of Ki67, high levels of cyclin D1, grade III tumours, and HER2-positive tumours. This evidence concerns the gene ERBB2 and neoplasm.